Abstract
Myxothiazol, a new antibiotic from the myxobacterium Myxococcus fulvus, inhibited the growth of many yeasts and fungi at concentrations between 0.01 and 3 micrograms/ml. It was generally inactive against bacteria. The inhibitory effect was cytostatic. With Candida albicans, Saccharomyces cerevisiae, and Mucor hiemalis, the growth inhibition was neutralized by glucose. Soon after being added to a cell suspension, the compound almost completely blocked oxygen consumption.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AHMAD K., SCHNEIDER H. G., STRONG F. M. Studies on the biological action of antimycin A. Arch Biochem. 1950 Sep;28(2):281–294. [PubMed] [Google Scholar]
- Gerth K., Irschik H., Reichenbach H., Trowitzsch W. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) 1980 Dec;33(12):1474–1479. doi: 10.7164/antibiotics.33.1474. [DOI] [PubMed] [Google Scholar]
- Kneifel H., König W. A., Loeffler W., Müller R. Ophiocordin, an antifungal antibiotic of Cordyceps ophioglossoides. Arch Microbiol. 1977 May 13;113(1-2):121–130. doi: 10.1007/BF00428591. [DOI] [PubMed] [Google Scholar]
- Shepherd M. G., Chin C. M., Sullivan P. A. The alternate respiratory pathway of Candida albicans. Arch Microbiol. 1978 Jan 23;116(1):61–67. doi: 10.1007/BF00408734. [DOI] [PubMed] [Google Scholar]
- Subík J., Behún M., Smigán P., Musílek V. Mode of action of mucidin, a new antifungal antibiotic produced by the basidiomycete Oudemansiella mucida. Biochim Biophys Acta. 1974 Apr 22;343(2):363–370. [PubMed] [Google Scholar]
- Trowitzsch W., Reifenstahl G., Wray V., Gerth K. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). II. structure elucidation. J Antibiot (Tokyo) 1980 Dec;33(12):1480–1490. doi: 10.7164/antibiotics.33.1480. [DOI] [PubMed] [Google Scholar]